There have been 50 recent insider transactions recorded for Inovio Pharmaceuticals, Inc. (INO), including 20 buys and 30 sells.
Notable insiders with recent activity include Sumner Michael John, Kies Peter, Humeau Laurent. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — INO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
4,292 |
- |
- |
- |
| 2026-03-04 |
Kies Peter |
CFO |
RSU Award |
25,520 |
- |
- |
25,520 |
| 2026-03-04 |
Humeau Laurent |
Chief Scientific Officer |
RSU Award |
21,560 |
- |
- |
21,560 |
| 2026-03-04 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
RSU Award |
78,760 |
- |
- |
78,760 |
| 2026-03-04 |
Sumner Michael John |
Chief Medical Officer |
RSU Award |
29,608 |
- |
- |
29,608 |
| 2026-02-26 |
Kies Peter |
CFO |
Option Exercise (Sell) |
5,010 |
- |
- |
5,009 |
| 2026-02-26 |
Weiner David B. |
Director |
Option Exercise (Sell) |
972 |
- |
- |
- |
| 2026-02-26 |
Humeau Laurent |
Chief Scientific Officer |
Option Exercise (Sell) |
5,010 |
- |
- |
5,009 |
| 2026-02-26 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
Option Exercise (Sell) |
18,632 |
- |
- |
18,631 |
| 2026-02-26 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
5,010 |
- |
- |
5,009 |
| 2025-06-30 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
2,916 |
- |
- |
- |
| 2025-05-21 |
Yarno Wendy L |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-21 |
Benito Simon X |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-21 |
Zoth Lota S. |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-21 |
Shepard Jay |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-21 |
Weiner David B. |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-21 |
Dansey Roger D |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-21 |
Miller Ann Calby |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
- |
| 2025-05-20 |
Kies Peter |
CFO |
RSU Award |
26,100 |
- |
- |
26,100 |
| 2025-05-20 |
Humeau Laurent |
Chief Scientific Officer |
RSU Award |
18,081 |
- |
- |
18,081 |
| 2025-05-20 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
RSU Award |
84,888 |
- |
- |
84,888 |
| 2025-05-20 |
Sumner Michael John |
Chief Medical Officer |
RSU Award |
28,350 |
- |
- |
28,350 |
| 2025-05-15 |
Kies Peter |
CFO |
Option Exercise (Sell) |
4,771 |
- |
- |
4,771 |
| 2025-05-15 |
Humeau Laurent |
Chief Scientific Officer |
Option Exercise (Sell) |
4,771 |
- |
- |
4,771 |
| 2025-05-15 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
Option Exercise (Sell) |
17,744 |
- |
- |
17,744 |
| 2025-05-15 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
2,385 |
- |
- |
2,385 |
| 2025-05-10 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
Option Exercise (Sell) |
5,500 |
- |
- |
- |
| 2025-02-27 |
Kies Peter |
CFO |
RSU Award |
31,900 |
- |
- |
31,900 |
| 2025-02-27 |
Humeau Laurent |
Chief Scientific Officer |
RSU Award |
22,098 |
- |
- |
22,098 |
| 2025-02-27 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
RSU Award |
85,201 |
- |
- |
85,201 |
| 2025-02-27 |
Sumner Michael John |
Chief Medical Officer |
RSU Award |
34,650 |
- |
- |
34,650 |
| 2025-02-26 |
Kies Peter |
CFO |
Option Exercise (Sell) |
3,997 |
- |
- |
- |
| 2025-02-26 |
Weiner David B. |
Director |
Option Exercise (Sell) |
972 |
- |
- |
- |
| 2025-02-26 |
Humeau Laurent |
Chief Scientific Officer |
Option Exercise (Sell) |
3,855 |
- |
- |
- |
| 2025-02-26 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
Option Exercise (Sell) |
5,852 |
- |
- |
- |
| 2025-02-26 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
5,010 |
- |
- |
10,019 |
| 2024-12-18 |
Sumner Michael John |
Chief Medical Officer |
RSU Award |
4,292 |
- |
- |
4,292 |
| 2024-06-30 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
2,917 |
- |
- |
2,916 |
| 2024-05-21 |
Yarno Wendy L |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Benito Simon X |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Zoth Lota S. |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Shepard Jay |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Weiner David B. |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Dansey Roger D |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-21 |
Miller Ann Calby |
Director |
RSU Award |
2,167 |
- |
- |
2,167 |
| 2024-05-15 |
Yarno Wendy L |
Director |
Option Exercise (Sell) |
2,166 |
- |
- |
- |
| 2024-05-15 |
Kies Peter |
CFO |
Option Exercise (Sell) |
4,771 |
- |
- |
9,542 |
| 2024-05-15 |
Benito Simon X |
Director |
Option Exercise (Sell) |
2,166 |
- |
- |
- |
| 2024-05-15 |
Zoth Lota S. |
Director |
Option Exercise (Sell) |
2,166 |
- |
- |
- |
| 2024-05-15 |
Shepard Jay |
Director |
Option Exercise (Sell) |
2,166 |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
